Search Within

Eileen O'Reilly

Formats
  1. Meeting Abstract (364)
  2. Journal Article (358)
  3. Review (24)
  4. Book Section (9)
  5. Correspondence (9)
  6. Editorial (8)
  7. Conference Paper (5)
  8. Miscellaneous (5)
  9. Book Whole (4)
  10. Guidelines (3)
  11. Research Letter (1)
Groups
  1. Center for Pancreatic Cancer Research (790)
  2. Department of Medicine (790)
  3. Gastrointestinal Oncology Service (790)
  4. Solid Tumor Oncology Division (790)
  5. Epidemiology and Biostatistics (178)
  6. Surgery (168)

More Groups

People
  1. Ghassan Abou-Alfa (156)
  2. Kenneth Yu (121)
  3. David Kelsen (112)
  4. Maeve Lowery (99)
  5. Marinela Capanu (94)
  6. William Jarnagin (84)

More People

Years
  1. 2025 (38)
  2. 2024 (75)
  3. 2023 (73)
  4. 2022 (57)
  5. 2021 (54)
  6. 2020 (70)

More Years

Publications
  1. Journal of Clinical Oncology (294)
  2. Annals of Oncology (48)
  3. Cancer (27)
  4. Annals of Surgical Oncology (26)
  5. Clinical Cancer Research (23)
  6. Gastrointestinal Cancer Research (18)

More Publications

Publishers
  1. American Society of Clinical Oncology (308)
  2. Oxford University Press (71)
  3. Elsevier Inc. (49)
  4. Springer (47)
  5. Wiley Blackwell (42)
  6. American Association for Cancer Research (40)

More Publishers

Results (790)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Overall survival and clinical characteristics of BRCA mutation carriers with stage I/II pancreatic cancer
    Journal Article

    Golan, T.; Sella, T.; O'Reilly, E. M.; Katz, M. H. G.; Epelbaum, R.; Kelsen, D. P.; Borgida, A.; Maynard, H.; Kindler, H.; Friedmen, E.; more...
    British Journal of Cancer (2017)

    Fulltext@MSK | Save
  • Chemotherapy and intensity-modulated radiation therapy for locally advanced pancreatic cancer achieves a high rate of R0 resection*
    Journal Article

    Huguet, F.; Hajj, C.; Winston, C. B.; Shi, W.; Zhang, Z.; Wu, A. J.; O’Reilly, E. M.; Reidy, D. L.; Allen, P.; Goodman, K. A.
    Acta Oncologica (2017)

    Fulltext@MSK | Save
  • A novel scoring system to predict survival in patients with advanced pancreatic adenocarcinoma: The Memorial Prognostic Score (MPS)
    Meeting Abstract

    Yang, A. C.; Wiesenthal, A.; Epstein, A. S.; Zheng, J.; Goldberg, J.; Meadows, J.; O'Reilly, E. M.; Glare, P. A.
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save
  • Breast cancer resistance protein (ABCG2) as a potential biomarker for gemcitabine and nab-paclitaxel sensitivity
    Meeting Abstract

    Yu, K. H.; Ricigliano, M.; O'Reilly, E. M.; Lowery, M. A.; Cooper, B.; Covington, C. M.
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save
  • Impact of primary (1º) tumor location on overall survival (OS) and progression-free survival (PFS) in patients (pts) with metastatic colorectal cancer (mCRC): Analysis of CALGB/SWOG 80405 (Alliance)
    Meeting Abstract

    Venook, A. P.; Niedzwiecki, D.; Innocenti, F.; Fruth, B.; Greene, C.; O'Neil, B. H.; Shaw, J. E.; Atkins, J. N.; Horvath, L. E.; Polite, B. N.; more...
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save
  • Do pancreatic cancer (PDA) stem cell markers predict biologic behavior?
    Meeting Abstract

    Sahin, I. H.; Turkekul, M.; Capanu, M.; Askan, G.; McMahon, B.; Yu, K. H.; Lowery, M. A.; Basturk, O.; Iacobuzio-Donahue, C.; O'Reilly, E. M.
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save
  • Expression levels of aldehyde dehydrogenase 1A1 (ALDH1A1) in circulating tumor and invasive cells (CTICs) as a biomarker for drug resistance and disulfiram in pancreatic adenocarcinoma (PDAC)
    Meeting Abstract

    Ricigliano, M.; Cooper, B.; Ocean, A. J.; Tiriac, H.; Tuveson, D. A.; Yu, K. H.; O'Reilly, E. M.
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save
  • Safety, pharmacokinetics, pharmacodynamics, and antitumor activity of necuparanib combined with nab-paclitaxel and gemcitabine in patients with metastatic pancreatic cancer: Updated phase 1 results
    Meeting Abstract

    O'Reilly, E. M.; Mahalingam, D.; Roach, J. M.; Miller, P. J.; Rosano, M. E.; Krause, S.; Wolf, J.; Flaherty, K.; Ryan, D. P.
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save
  • A phase 2, open-label, multicenter study of durvalumab (MEDI4736) ± tremelimumab in patients (pts) with metastatic pancreatic ductal adenocarcinoma (mPDAC): ALPS
    Meeting Abstract

    O'Reilly, E. M.; Oh, D. Y.; Lee, M. A.; Dhani, N.; Armstrong, J.; Belli, R.; Ferro, S.; Ben, Y.
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save
  • Comprehensive molecular profiling and analysis of mutual exclusivity of genetic aberrations (MEGA) of intra- and extrahepatic cholangiocarcinomas (IHC and EHC) evaluation of prognostic features and potential targets for intervention
    Meeting Abstract

    Lowery, M. A.; Ptashkin, R.; Jordan, E.; Berger, M. F.; Zehir, A.; Kemeny, N. E.; O'Reilly, E. M.; Jarnagin, W. R.; Harding, J. J.; DeMatteo, R. P.; more...
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save